European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetes

Cel

An absolute or relative loss of beta-cell mass and function underlie the development of type I and type 2 diabetes.Preventing beta-cell demise or restoring their number and function is a major therapeutic goal. However,development of novel diagnostic and prognostic tools, and of novel therapeutic modalities, is hampered by the limited knowledge of the molecular pathways that control beta-cell demise in diabetes, the production of new beta-cells from progenitors,or the replication and preserved function of mature beta-cells. Here,we propose an integrated approach to generate and exploit new
cellular and animal models, and to develop novel investigative tools and biomarkers to gain new knowledge on the mechanisms of beta-cell function and demise in diabetes, to improve diabetes diagnostic and to identify novel therapeutic targets for drug development. To achieve this ambitious goal,we have established a consortium of leading European experts from universities and SMEs in the fields of beta-cell diabetes research,
gene transfer technology, metabolom ics, biomedical imaging, bioinformatics and systems
modeling. We propose a work plan composed of 5 scientific work packages structured to provide high levels of interaction within the network and with EFPIA partners.
A management and administration work package will permit an efficient cooperation between
universities, SMEs and industrial partners to ensure that the particular interests and
needs of pharmaceutical industry research are addressed.

Zaproszenie do składania wniosków

IMI-JU-01-2008
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

SANOFI-AVENTIS DEUTSCHLAND GMBH
Wkład UE
Brak danych
Adres
BRUNINGSTRASSE 50
65929 Frankfurt Am Main
Niemcy

Zobacz na mapie

Region
Hessen Darmstadt Frankfurt am Main, Kreisfreie Stadt
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Kierownik naukowy
Werner Kramer (Prof. Dr. Dr.)
Kontakt administracyjny
Peter Hecht (Dr.)
Linki
Koszt całkowity
Brak danych

Uczestnicy (20)